Prevail Therapeutics Inc.

FEDERATED HERMES, INC.

Report date

9/30/2020

Quarter

2020 Q3

Filed

11/12/2020

Shares

190,034

Value ($000)

1,935

Weight

0.0%

2020 Q2 - 2020 Q3 (2 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2020 Q3	11/12/2020	1,935	0.0%	190,034	9/30/2020
2020 Q2	8/13/2020	2,645	0.0%	177,547	6/30/2020